Omeros reported $313.02M in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acelrx Pharmaceuticals ACRX:US $ 15.73M 2.41M
Adamas Pharmaceuticals ADMS:US 129.04M 671K
Adma Biologics ADMA:US $ 94.36M 0.49M
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Biomarin Pharmaceutical BMRN:US $ 1078.09M 0.98M
Cytokinetics CYTK:US $ 140.96M 1.83M
Dynavax Technologies DVAX:US $ 220.22M 0.26M
Heron Therapeutics HRTX:US $ 149.03M 0.05M
Insmed INSM:US $ 572.61M 8.59M
Intercept Pharmaceuticals ICPT:US $ 530.4M 45.42M
Knight Therapeutics Inc GUD:CN C$ 40.52M 634K
Macrogenics MGNX:US $ 0M 0M
Mirati Therapeutics MRTX:US $ 0M 0M
Omeros OMER:US $ 313.02M 433K
Pacira Pharmaceuticals PCRX:US $ 481.9M 6.51M
Rockwell Medical RMTI:US $ 22.54M 1.4M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M
Xoma XOMA:US $ 0 0